Biprost reduces IOP by increasing aqueous aqueous outflow from the trabecular network channel and uveal scleral channel and reducing superficial scleral venous pressure. Brukaker et al. showed that 0.03% biprost could reduce iOP by 20%, the tension resistance of aqueous aqueous outflow by 26% and the surface resistance of aqueous aqueous outflow by 31% in normal volunteers.

Rizhao Beida Biotechnology Co., Ltd is located in Rizhao City in Shandong Province, China. It is a enterprise specialized in the research, production and sale of  medical apparatus ,biochemical and pharmaceutical raw materials. The high quality, integrity and global marketing network enable our company to win high praise home and abroad including in Europe, America, Japan and Southeast Asia. 

With a wide range, good quality, reasonable prices and stylish designs, our products are extensively used in cosmetic and plastic surgery and other industries. We can also provide OEM and ODM service.We are looking forward to establishing a long-term business relationship with overseas in the near future based on mutual benefits.